LetterCancer

Response to comment on “NRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis”

See allHide authors and affiliations

Science Translational Medicine  27 Jul 2016:
Vol. 8, Issue 349, pp. 349lr1
DOI: 10.1126/scitranslmed.aag1805

You are currently viewing the abstract.

View Full Text

Abstract

Multiple factors may affect the outcome of diabetic patients with cancer treated with antioxidant antidiabetic agents.

View Full Text